Document is current
Any future updates will be listed below
-
Authors
Hantel, Andrew
Senay, Emily
Hlubocky, Fay J.
Walsh, Thomas P.
Gallagher, Erin
Johnston, Hannah
Cronin, Angel
DuVall, Adam S.
Revette, Anna C.
Nava-Coulter, Brett
Siegler, Mark
Richie, Cristina
Abel, Gregory A.
-
Funding
Funding for this research was provided by:
Greenwall Foundation
- License Information
-
More Information
Article History
Received: 3 September 2025
Accepted: 19 January 2026
First Online: 27 January 2026
Declarations
:
: The Dana-Farber/Harvard Cancer Center, University of Chicago Medicine, and Mount Sinai Hospital institutional review boards provided ethical approval for the study (reference IDs 22-616 and 22-01009). Participants consented to the survey at the time of participation
: Not applicable.
: Dr. Hantel reports receiving personal fees from AbbVie, AstraZeneca, BMS, Celgene, GSK, American Journal of Managed Care, Jazz, and Genentech and employment at Real Chemistry (immediate family member) outside the submitted work. Ms. Cronin reports prior employment at Revitas and employment at Pulse Infoframe (immediate family member) employment and stock at Vertex Pharmaceuticals outside the submitted work. Dr. DuVall reports receiving personal fees from Aptitude Health, BioAscend, CME Concepts, Novartis, and Sago Marketing outside the submitted work. The other authors report no conflicts of interest.
